INERGETICS INC

Profile

Company Names

INERGETICS INC
MILLENNIUM BIOTECHNOLOGIES GROUP INC

Addresses

550 BROAD STREET, SUITE 1212, NEWARK, NJ 07102

665 MARTINSVILLE ROAD, SUITE 219, BASKING RIDGE, NJ 07920

Phone Numbers

908-604-2500
(908) 604-2500

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$6,747,984.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2015-03-11 
$150,000.00 
$150,000.00 
$0.00 
Equity, Debt 
7
2015-02-17 
$150,000.00 
$150,000.00 
$0.00 
Equity, Debt 
6
2014-11-18 
$75,000.00 
$75,000.00 
$0.00 
Equity, Debt 
5
2014-10-27 
$150,000.00 
$150,000.00 
$0.00 
Equity, Debt 
4
2014-07-14 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
3
2014-05-21 
$511,146.00 
INDEFINITE 
INDEFINITE 
Equity, Debt 
2
2014-05-12 
$110,000.00 
$110,000.00 
$0.00 
 
1
2009-11-10 
$4,601,838.00 
$7,500,000.00 
$2,898,162.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BENJAMIN 
 
CUSTODIO 
DIRECTOR
MILLENNIUM BIOTECHNOLOGIES GROUP INC
JAMES 
 
DELUCIA 
DIRECTOR
INERGETICS INC
CARL 
 
GERMANO 
EXECUTIVE OFFICER, DIRECTOR
MILLENNIUM BIOTECHNOLOGIES GROUP INC   |  INERGETICS INC
FRANK 
 
GUARINO 
EXECUTIVE OFFICER
MILLENNIUM BIOTECHNOLOGIES GROUP INC   |  INERGETICS INC   |  ALITAIR PHARMACEUTICALS, INC.
MICHAEL 
 
JAMES 
DIRECTOR, EXECUTIVE OFFICER
US TELEPACIFIC HOLDINGS CORP   |  MILLENNIUM BIOTECHNOLOGIES GROUP INC   |  TERRA TECH CORP.   |  INERGETICS INC   |  GUERNSEY HOLDINGS LLC   |  GH 7B HOLDCO LLC   |  GUERNSEY HOLDINGS ZRC HOLDCO, LLC
JAMES 
 
KRAS 
EXECUTIVE OFFICER, DIRECTOR
INERGETICS INC
MARK 
C. 
MIRKEN 
DIRECTOR, EXECUTIVE OFFICER
MILLENNIUM BIOTECHNOLOGIES GROUP INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-03-12
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-03-11 
2015-02-20
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-02-17 
2014-11-21
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-11-18 
2014-10-30
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-10-27 
2014-07-15
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-07-14 
2014-05-30
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2014-05-21 
2014-05-23
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2014-05-12 
2009-11-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity, Debt 
2009-11-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AEGIS CAPITAL CORP.
15007
NONE
NONE
TRIPOINT GLOBAL EQUITIES, LLC
143174